| Q1 2024 |
187 |
$7.17B |
+$404M |
-$966M |
-$562M |
AVGO, C, T, JPM, CME, MRK |
13F-HR |
5/13/2024, 04:58 PM |
| Q4 2023 |
196 |
$6.93B |
+$647M |
-$470M |
+$177M |
AVGO, C, CME, T, JPM, QCOM |
13F-HR |
2/8/2024, 11:15 AM |
| Q3 2023 |
195 |
$6.07B |
+$480M |
-$445M |
+$35.8M |
AVGO, CME, PFE, JPM, C, QCOM |
13F-HR |
11/13/2023, 10:38 AM |
| Q2 2023 |
184 |
$6.17B |
+$433M |
-$597M |
-$165M |
AVGO, CME, PFE, JPM, QCOM, RF |
13F-HR |
8/8/2023, 04:04 PM |
| Q1 2023 |
185 |
$6.05B |
+$327M |
-$293M |
+$33.8M |
AVGO, CME, PFE, JPM, QCOM, RF |
13F-HR |
5/9/2023, 01:01 PM |
| Q4 2022 |
201 |
$5.91B |
+$254M |
-$512M |
-$258M |
PFE, AVGO, CME, JPM, RF, QCOM |
13F-HR |
2/7/2023, 05:23 PM |
| Q3 2022 |
200 |
$5.65B |
+$410M |
-$581M |
-$171M |
CME, PFE, AVGO, RF, QCOM, JPM |
13F-HR |
11/14/2022, 04:59 PM |
| Q2 2022 |
201 |
$6.53B |
+$669M |
-$465M |
+$204M |
CME, ABBV, AVGO, PFE, QCOM, JPM |
13F-HR |
8/5/2022, 02:04 PM |
| Q1 2022 |
196 |
$7.63B |
+$411M |
-$572M |
-$161M |
CME, AVGO, ABBV, PFE, QCOM, JPM |
13F-HR |
5/11/2022, 06:23 PM |
| Q4 2021 |
208 |
$8.53B |
+$803M |
-$822M |
-$18.7M |
AVGO, CME, ABBV, QCOM, PFE, JPM |
13F-HR |
2/10/2022, 04:22 PM |
| Q3 2021 |
209 |
$8.15B |
+$707M |
-$882M |
-$175M |
CME, AVGO, ABBV, JPM, HD, CIM |
13F-HR |
11/9/2021, 05:23 PM |
| Q2 2021 |
1 |
$9.01M |
|
|
|
GTES |
NEW HOLDINGS |
10/12/2021, 04:08 PM |
| Q2 2021 |
206 |
$8.7B |
+$676M |
-$634M |
+$42M |
CME, JPM, ABBV, AVGO, CIM, QCOM |
13F-HR |
8/10/2021, 06:55 PM |
| Q1 2021 |
207 |
$8.62B |
+$719M |
-$690M |
+$29.6M |
JPM, CME, ABBV, AVGO, BABA, HD |
13F-HR |
5/14/2021, 03:38 PM |
| Q4 2020 |
227 |
$8.43B |
+$1.71B |
-$1.92B |
-$210M |
CME, JPM, AVGO, ABBV, BABA, QCOM |
13F-HR |
2/9/2021, 12:51 PM |
| Q3 2020 |
164 |
$7.56B |
+$343M |
-$836M |
-$493M |
BABA, JPM, CME, ABBV, HD, AVGO |
13F-HR |
11/5/2020, 12:06 PM |
| Q2 2020 |
159 |
$7.79B |
+$800M |
-$1.24B |
-$442M |
ABBV, BABA, JPM, CME, HD, AVGO |
13F-HR |
8/7/2020, 02:17 PM |
| Q1 2020 |
163 |
$6.99B |
+$697M |
-$1.21B |
-$514M |
BABA, CME, JPM, WBA, RDSA, MRK |
13F-HR |
5/13/2020, 01:43 PM |
| Q4 2019 |
171 |
$10.4B |
+$500M |
-$981M |
-$481M |
CME, JPM, RDSA, BABA, QCOM, HD |
13F-HR |
2/7/2020, 05:05 PM |
| Q3 2019 |
170 |
$10.4B |
+$576M |
-$481M |
+$95.3M |
CME, JPM, RDSA, BABA, HD, QCOM |
13F-HR |
11/12/2019, 12:20 PM |
| Q2 2019 |
170 |
$10.4B |
+$723M |
-$810M |
-$87.5M |
CME, RDSA, JPM, BABA, QCOM, HD |
13F-HR |
8/6/2019, 12:04 PM |
| Q1 2019 |
175 |
$10.3B |
+$640M |
-$1.18B |
-$540M |
RDSA, CME, JPM, BABA, WBA, MRK |
13F-HR |
5/7/2019, 04:00 PM |
| Q4 2018 |
171 |
$10.2B |
+$766M |
-$583M |
+$183M |
CME, RDSA, JPM, WBA, QCOM, MRK |
13F-HR |
2/6/2019, 03:00 PM |
| Q3 2018 |
161 |
$12B |
+$811M |
-$985M |
-$174M |
RDSA, CME, JPM, WBA, QCOM, HD |
13F-HR |
11/2/2018, 10:58 AM |
| Q2 2018 |
227 |
$13.2B |
+$1.06B |
-$1.22B |
-$160M |
RDSA, CME, JPM, WBA, HD, QCOM |
13F-HR |
8/14/2018, 10:38 AM |
| Q1 2018 |
231 |
$13.3B |
+$1.27B |
-$1.05B |
+$228M |
RDSA, CME, JPM, WBA, HD, T |
13F-HR |
5/7/2018, 10:43 AM |
| Q4 2017 |
243 |
$14.4B |
+$1.22B |
-$901M |
+$319M |
JPM, CME, RDSA, HD, QCOM, T |
13F-HR |
2/14/2018, 09:17 AM |
| Q3 2017 |
243 |
$14B |
+$1.91B |
-$949M |
+$962M |
JPM, CME, RDSA, HD, MRK, MFAXXXX |
13F-HR |
11/13/2017, 08:59 AM |
| Q2 2017 |
249 |
$13.1B |
+$1.75B |
-$968M |
+$782M |
JPM, CME, RDSA, HD, MRK, BABA |
13F-HR |
8/14/2017, 10:22 AM |
| Q1 2017 |
265 |
$12.3B |
+$1.47B |
-$2.25B |
-$774M |
JPM, CME, RDSA, HD, WBA, MRK |
13F-HR |
5/9/2017, 10:36 AM |
| Q4 2016 |
273 |
$13B |
+$1.39B |
-$1.5B |
-$111M |
JPM, CME, RDSA, HD, WBA, MRK |
13F-HR |
2/10/2017, 12:48 PM |
| Q3 2016 |
254 |
$13.1B |
+$1.21B |
-$1.11B |
+$97.8M |
JPM, CME, RDSA, AGN, HD, MRK |
13F-HR |
11/14/2016, 08:27 AM |
| Q2 2016 |
260 |
$12.9B |
+$1.35B |
-$2.55B |
-$1.2B |
JPM, RDSA, CME, AGN, HD, T |
13F-HR |
8/12/2016, 12:05 PM |
| Q1 2016 |
264 |
$15B |
+$2.12B |
-$1.95B |
+$166M |
JPM, CME, HD, T, C, RDSA |
13F-HR |
5/12/2016, 10:58 AM |
| Q4 2015 |
292 |
$15.7B |
+$1.61B |
-$1.7B |
-$87.7M |
CME, JPM, HD, T, RDSA, LBTYK |
13F-HR |
2/9/2016, 10:57 AM |
| Q3 2015 |
275 |
$15.9B |
+$3.2B |
-$1.55B |
+$1.65B |
CME, JPM, HD, T, AGN, RDSA |
13F-HR |
11/12/2015, 09:17 AM |
| Q2 2015 |
305 |
$17.4B |
+$3.61B |
-$3.08B |
+$529M |
CME, JPM, RDSA, HD, LBTYK, VOD |
13F-HR |
8/12/2015, 09:25 AM |
| Q1 2015 |
306 |
$18B |
+$2.49B |
-$3.62B |
-$1.13B |
JPM, CME, RDSA, NXPI, LBTYK, HD |
13F-HR |
5/13/2015, 11:53 AM |
| Q4 2014 |
303 |
$20B |
+$2.74B |
-$3.75B |
-$1.01B |
JPM, RDSA, LBTYK, BIDU, BABA, CME |
13F-HR |
2/11/2015, 10:04 AM |
| Q3 2014 |
312 |
$22.2B |
+$2.5B |
-$3.9B |
-$1.4B |
JPM, BIDU, B108PS, LBTYK, SLB, RDSA |
13F-HR |
11/12/2014, 09:07 AM |
| Q2 2014 |
319 |
$25.1B |
+$4.35B |
-$4.09B |
+$261M |
SLB, BIDU, TSM, JPM, ACN, B108PS |
RESTATEMENT |
8/11/2014, 02:35 PM |
| Q1 2014 |
292 |
$25.4B |
+$4.29B |
-$3.35B |
+$943M |
SLB, BIDU, YUM, ACN, BBVA, TSM |
13F-HR |
5/14/2014, 04:41 PM |
| Q4 2013 |
284 |
$26.2B |
|
|
|
BIDU, SLB, YUM, YNDX, LBTYA, ACN |
13F-HR |
2/13/2014, 12:57 PM |